SCHEMBL262134

SCHEMBL262134

FC(F)(F)c1ccon1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4211437 0.81 KMT2A (0.32)
SCHEMBL27570211 0.76
SCHEMBL24050962 0.75
SCHEMBL10481210 0.74
SCHEMBL680606 0.74
SCHEMBL29899254 0.72
SCHEMBL12817376 0.70
SCHEMBL27256470 0.70 KDM4E (0.33)
SCHEMBL3082762 0.67 NPC1 (0.42)
SCHEMBL13236412 0.67 CYP1A2 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116621864-A Boron ester furan derivative compound and preparation method and application thereof 陕西师范大学 2023-08-22 CN claimed
CN-112898285-B Trifluoromethyl-containing bisoxazole compound, and synthesis method and application thereof in anti-cancer drugs 河南师范大学 2022-05-24 CN claimed
CN-106660994-A Phosphatidylinositol 3-kinase inhibitors 吉利德科学公司 2017-05-10 CN claimed
CN-102911131-B Double-bond trifluoromethyl isoxazole compound, preparation method and application thereof Sinochem Lantian Co., Ltd. (CN) 2014-10-29 CN claimed
CN-102911131-A Double-bond trifluoromethyl isoxazole compound, preparation method and application thereof SINOCHEM LANTIAN CO LTD 2013-02-06 CN claimed
CN-116621864-B Boron ester furan derivative compound and preparation method and application thereof 陕西师范大学 2025-09-12 CN disclosed
EP-4587424-A1 YAP/TAZ-TEAD ONCOPROTEINS INHIBITORS Bridgene Biosciences, Inc. (US) 2025-07-23 EP disclosed
US-20250129044-A1 PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS XENON PHARMACEUTICALS INC. (CA) 2025-04-24 US disclosed
US-12202826-B2 N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway REDX PHARMA PLC (GB) 2025-01-21 US disclosed
US-20250002487-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2025-01-02 US disclosed
US-20240336592-A1 PHENYL- AND PYRIDOPYRAZOLE DERIVATIVES AS INHIBITORS OF DDR1 REDX PHARMA PLC (GB) 2024-10-10 US disclosed
US-20240208992-A1 MACROCYCLES AS CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-27 US disclosed
WO-1998028282-A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-07-02 WO disclosed
EP-0699191-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-03-06 EP disclosed
WO-1994027979-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN IMMUNOPHARMACEUTICS, INC. (US) 1994-12-08 WO disclosed
EP-0245825-B1 STYRYL PYRAZOLES, ISOXAZOLES AND ANALOGS THEREOF HAVING ACTIVITY AS 5-LIPOXY-GENASE INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM WARNER-LAMBERT COMPANY (US) 1991-03-13 EP disclosed
EP-0371876-A1 Isoxazoles and isoxazolines with an anticonvulsive activity, and pharmaceutical compositions containing them NOVAPHARME (FR) 1990-06-06 EP disclosed
US-4906277-A Isoxazoline derivatives and plant growth regulators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1990-03-06 US disclosed
US-4889551-A Isoxazoline derivatives and plant growth regulators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1989-12-26 US disclosed
EP-0270963-A1 Fluor-containing 5-trihalogen methyl isoxazoles, and method for their preparation BAYER AG (DE) 1988-06-15 EP disclosed